Adult Growth Hormone Deficiency and Cardiovascular Risk

Summary

This protocol will assess the cardiovascular risk associated with growth hormone deficiency in adults. We will use multiple modalities to assess risk for heart attacks or strokes including blood work, ultrasound, MRI and endothelial cell biopsies in both patients who are growth hormone deficient and in patients with normal growth hormone secretion. We hypothesize that adults with growth hormone deficiency will have results suggestive of an increased risk for cardiovascular disease.

Timeline

Start

2007-02

Primary completion

2010-03

Completion

2011-05

Outcome

Outcome not reported

Stopped (Enrollment): “poor enrollment”

Drugs

Indications